Perrigo Company PLC’s planned acquisition of French firm HRA Pharma will not only bring additional products and markets, but also enhance the private label OTC giant’s outlook for being first in the US to introduce additional nonprescription ingredients.
HRA, officially identified in France as Hera SAS, brings needed expertise in OTC switches to Perrigo, which is regularly is...